
1. korean j urol. 2014 jan;55(1):9-16. doi: 10.4111/kju.2014.55.1.9. epub 2014 jan
15.

hypogonadism human immunodeficiency virus-positive men.

ashby j(1), goldmeier d(2), sadeghi-nejad h(3).

author information: 
(1)berkshire healthcare nhs foundation trust, slough, uk.
(2)imperial college healthcare nhs trust, st mary's hospital, london, uk.
(3)division urology, department surgery, umdnj new jersey medical school,
newark, nj, usa.

in recent years, life expectancy living human immunodeficiency
virus (hiv) access combined antiretroviral therapy (cart) increased. 
as men live longer, role testosterone plays sexual function well 
general well-being becoming increasingly important. discuss the
available literature concerning androgens hiv disease. review was
undertaken using pubmed search umbrella terms hiv aids and
testosterone androgens spanning 1985 2011. significant articles found in
references primary search also included. reported prevalence of
androgen deficiency appears greater hiv-infected males the
general population. androgen deficiency usually associated low
luteinizing hormone follicle-stimulating hormone sensitive type
of measurement testosterone used. rates hypogonadism may falling since
the advent cart. causes low testosterone levels attributed to
chronic illness, hiv replication, cart, opportunistic infections, comorbidities
and coinfections, wasting, normal age-related declines. studies of
testosterone treatment hiv-positive men lacking standardization and
outcome measures.

doi: 10.4111/kju.2014.55.1.9 
pmcid: pmc3897637
pmid: 24466391 

